The genetic studies show that deletion or inactivating mutation of A20 is associated with constitutive NF-κB activity and this contributes to hematological malignancies, suggesting a tumor suppressor role for A20 in these cancer types [40]. This evidence concerns the gene NFKB1 and hematologic disorder.